GALNT12 is Not a Major Contributor of Familial Colorectal Cancer Type X

Human Mutation

Volumn 35, Issue 1, 2014, Pages 50-52

  Seguí, Nuria ^a   Pineda, Marta ^a   Navarro, Matilde ^a   Lázaro, Conxi ^a   Brunet, Joan ^b   Infante, Mar ^c   Durán, Mercedes ^c   Soto, José Luis ^d   Blanco, Ignacio ^a   Capellá, Gabriel ^a   Valle, Laura ^a  

^a BELLVITGE BIOMEDICAL RESEARCH INSTITUTE IDIBELL   (Spain)

^b CATALAN INSTITUTE OF ONCOLOGY   (Spain)

^c University of Valladolid   (Spain)

^d Elche University Hospital   (Spain)

Author keywords

Colorectal cancer susceptibility; GALNT12; Hereditary colorectal cancer; Penetrance

Indexed keywords

ADULT; ARTICLE; CANCER SUSCEPTIBILITY; ENZYME ACTIVITY; EXON; FAMILIAL CANCER; GALNT12 GENE; GENE; GENE FREQUENCY; GENE MUTATION; GENETIC CODE; GENETIC SUSCEPTIBILITY; HEREDITARY COLORECTAL CANCER; HIGH RISK PATIENT; HUMAN; INTRON; MAJOR CLINICAL STUDY; MISMATCH REPAIR; MISSENSE MUTATION; PENETRANCE; PRIORITY JOURNAL;

COLORECTAL CANCER SUSCEPTIBILITY; GALNT12; HEREDITARY COLORECTAL CANCER; PENETRANCE;

3' UNTRANSLATED REGIONS; CHROMOSOMES, HUMAN, PAIR 9; COLORECTAL NEOPLASMS, HEREDITARY NONPOLYPOSIS; DNA MISMATCH REPAIR; EXONS; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MUTATION, MISSENSE; N-ACETYLGALACTOSAMINYLTRANSFERASES; PENETRANCE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEQUENCE ANALYSIS, DNA;

EID: 84890793126     PISSN: 10597794     EISSN: 10981004     Source Type: Journal    
DOI: 10.1002/humu.22454     Document Type: Article

References (15)

1. Burset M, Seledtsov IA, Solovyev VV. 2001. SpliceDB: database of canonical and non-canonical mammalian splice sites. Nucleic Acids Res 29(1):255-259.
2. Clarke E, Green RC, Green JS, Mahoney K, Parfrey PS, Younghusband HB, Woods MO. 2012. Inherited deleterious variants in GALNT12 are associated with CRC susceptibility. Hum Mutat 33(7):1056-1058.
3. Gray-McGuire C, Guda K, Adrianto I, Lin CP, Natale L, Potter JD, Newcomb P, Poole EM, Ulrich CM, Lindor N, Goode EL, Fridley BL, et al. 2010. Confirmation of linkage to and localization of familial colon cancer risk haplotype on chromosome 9q22. Cancer Res 70(13):5409-5418.
4. Guda K, Moinova H, He J, Jamison O, Ravi L, Natale L, Lutterbaugh J, Lawrence E, Lewis S, Willson JK, Lowe JB, Wiesner GL, et al. 2009. Inactivating germ-line and somatic mutations in polypeptide N-acetylgalactosaminyltransferase 12 in human colon cancers. Proc Natl Acad Sci USA 106(31):12921-12925.
5. Guo JM, Chen HL, Wang GM, Zhang YK, Narimatsu H. 2004. Expression of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase-12 in gastric and colonic cancer cell lines and in human colorectal cancer. Oncology 67(3-4):271-276.
6. Guo JM, Zhang Y, Cheng L, Iwasaki H, Wang H, Kubota T, Tachibana K, Narimatsu H. 2002. Molecular cloning and characterization of a novel member of the UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase family, pp-GalNAc-T12. FEBS Lett 524(1-3):211-218.
7. Hebsgaard SM, Korning PG, Tolstrup N, Engelbrecht J, Rouze P, Brunak S. 1996. Splice site prediction in Arabidopsis thaliana pre-mRNA by combining local and global sequence information. Nucleic Acids Res 24(17):3439-3452.
8. Kemp ZE, Carvajal-Carmona LG, Barclay E, Gorman M, Martin L, Wood W, Rowan A, Donohue C, Spain S, Jaeger E, Evans DG, Maher ER, et al. 2006. Evidence of linkage to chromosome 9q22.33 in colorectal cancer kindreds from the United Kingdom. Cancer Res 66(10):5003-5006.
9. Ku CS, Cooper DN, Wu M, Roukos DH, Pawitan Y, Soong R, Iacopetta B. 2012. Gene discovery in familial cancer syndromes by exome sequencing: prospects for the elucidation of familial colorectal cancer type X. Mod Pathol 25(8):1055-1068.
10. Lynch HT, Lynch PM, Lanspa SJ, Snyder CL, Lynch JF, Boland CR. 2009. Review of the Lynch syndrome: history, molecular genetics, screening, differential diagnosis, and medicolegal ramifications. Clin Genet 76(1):1-18.
11. Picelli S, Vandrovcova J, Jones S, Djureinovic T, Skoglund J, Zhou XL, Velculescu VE, Vogelstein B, Lindblom A. 2008. Genome-wide linkage scan for colorectal cancer susceptibility genes supports linkage to chromosome 3q. BMC Cancer 8:87.
12. Reese MG, Eeckman FH, Kulp D, Haussler D. 1997. Improved splice site detection in Genie. J Comput Biol 4(3):311-323.
13. Skoglund J, Djureinovic T, Zhou XL, Vandrovcova J, Renkonen E, Iselius L, Bisgaard ML, Peltomaki P, Lindblom A. 2006. Linkage analysis in a large Swedish family supports the presence of a susceptibility locus for adenoma and colorectal cancer on chromosome 9q22.32-31.1. J Med Genet 43(2):e7.
14. Tomlinson I, Rahman N, Frayling I, Mangion J, Barfoot R, Hamoudi R, Seal S, Northover J, Thomas HJ, Neale K, Hodgson S, Talbot I, et al. 1999. Inherited susceptibility to colorectal adenomas and carcinomas: evidence for a new predisposition gene on 15q14-q22. Gastroenterology 116(4):789-795.
15. Wiesner GL, Daley D, Lewis S, Ticknor C, Platzer P, Lutterbaugh J, MacMillen M, Baliner B, Willis J, Elston RC, Markowitz SD. 2003. A subset of familial colorectal neoplasia kindreds linked to chromosome 9q22.2-31.2. Proc Natl Acad Sci USA 100(22):12961-12965.